Pass the disruption

Credit: Courtesy of Michael Skinner" /> Credit: Courtesy of Michael Skinner The paper: M.D. Anway et al., "Epigenetic transgenerational actions of endocrine disruptors and male fertility," Science, 308:1466-9, 2005. (Cited in 112 papers) The finding: A group led by Michael Skinner from Washington State University briefly exposed pregnant female rats to endocrine disruptors and found sperm defects in the F1 generation of male rats, which were passe

Written byKelly Rae Chi
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The paper:
M.D. Anway et al., "Epigenetic transgenerational actions of endocrine disruptors and male fertility," Science, 308:1466-9, 2005. (Cited in 112 papers)

The finding:
A group led by Michael Skinner from Washington State University briefly exposed pregnant female rats to endocrine disruptors and found sperm defects in the F1 generation of male rats, which were passed through the male germ line to the F4 generation. Offspring of treated rats also had DNA methylation differences. "Potentially this transgenerational epigenetic mechanism could be how the environment is influencing disease," says Skinner.

The significance:
The study provided clear evidence of multigenerational effects of environmental exposure, says Andrea Gore, from University of Texas, Austin, who has since collaborated with Skinner's group.

The catch: Doses used in the study were higher than those seen in the environment, the authors note. "All bets are off when you extrapolate the findings" to humans or other animals, says ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies